
|Articles|February 9, 2022
Webinar: The Necessity of Extractables & Leachables Qualifications for Lyophilized Drug Products
Author(s)Nelson Labs
When selecting and qualifying the primary packaging for lyophilized drug products (LDPs), one of the obvious questions is How far should one go into the E&L-qualification process? As the drug product is in a solid state, one would expect that the interaction between the LDP and the components of its container would be low. But is this really the case? Watch this webinar to learn more.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Trending on Pharmaceutical Technology
1
How ten23 health is Advancing Patient-Centric Drug Delivery
2
Industry Expert Panel Weighs CNPV Benefits, Risks, and Readiness: Part II
3
FDA, Duke University Planning Epinephrine Access Workshop for December
4
Drug Solutions Podcast: Innovations in Orphan Drugs for Rare Diseases
5
